
NASDAQHealthcareMedical - Instruments & Supplies
أحدث البيانات المتاحة
11.23 US$
−2.96 US$ · -20.86%
AngioDynamics, Inc. specializes in the development, manufacturing, and commercialization of a diverse array of medical, surgical, and diagnostic instruments. These products are utilized by healthcare professionals to address conditions such as peripheral vascular disease, facilitate vascular access, and support various oncology and surgical interventions, serving both domestic and international markets. The company's portfolio includes advanced ablation systems like NanoKnife, designed for the precise surgical removal of soft tissues, and Solero microwave and radiofrequency systems, effective in ablating solid cancerous or benign growths. Additionally, they provide BioSentry tract sealant systems, IsoLoc Endorectal Balloons, Alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. Their endovascular therapies segment encompasses solutions for thrombus management, atherectomy procedures, core peripheral products, and the treatment of venous insufficiency. Furthermore, AngioDynamics is a key supplier of vascular access devices, such as peripherally inserted central catheters (PICCs), midline catheters, implantable ports, and dialysis catheters, along with associated accessories. These are primarily employed for short-duration systemic drug delivery, including chemotherapy and antibiotics, marketed under a robust portfolio of brand names such as BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax. The company distributes its offerings directly to a specialized clientele, including interventional radiologists, cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses, while also leveraging established distributor networks. Founded in 1988, AngioDynamics maintains its corporate headquarters in Latham, New York.
الإغلاق السابق
11.23 US$
−2.96 US$ · -20.86%
قبل افتتاح السوق
11.32 US$
+0.09 US$ · +0.80%
9 أكتوبر، 9:00 ص ET
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
AngioDynamics, Inc. specializes in the development, manufacturing, and commercialization of a diverse array of medical, surgical, and diagnostic instruments. These products are utilized by healthcare professionals to address conditions such as peripheral vascular disease, facilitate vascular access, and support various oncology and surgical interventions, serving both domestic and international markets. The company's portfolio includes advanced ablation systems like NanoKnife, designed for the precise surgical removal of soft tissues, and Solero microwave and radiofrequency systems, effective in ablating solid cancerous or benign growths. Additionally, they provide BioSentry tract sealant systems, IsoLoc Endorectal Balloons, Alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. Their endovascular therapies segment encompasses solutions for thrombus management, atherectomy procedures, core peripheral products, and the treatment of venous insufficiency. Furthermore, AngioDynamics is a key supplier of vascular access devices, such as peripherally inserted central catheters (PICCs), midline catheters, implantable ports, and dialysis catheters, along with associated accessories. These are primarily employed for short-duration systemic drug delivery, including chemotherapy and antibiotics, marketed under a robust portfolio of brand names such as BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax. The company distributes its offerings directly to a specialized clientele, including interventional radiologists, cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses, while also leveraging established distributor networks. Founded in 1988, AngioDynamics maintains its corporate headquarters in Latham, New York.
نطاق اليوم
السعر الحالي 11.23 US$
نطاق 52 أسبوعًا
السعر الحالي 11.23 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
احتفاظ
تقييم
48
قيمة عادلة
المشاعر
43
مختلط
المخاطر
33
مخاطر متوسطة
الزخم
54
محايد
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
AngioDynamics, Inc. specializes in the development, manufacturing, and commercialization of a diverse array of medical, surgical, and diagnostic instruments. These products are utilized by healthcare professionals to address conditions such as peripheral vascular disease, facilitate vascular access, and support various oncology and surgical interventions, serving both domestic and international markets. The company's portfolio includes advanced ablation systems like NanoKnife, designed for the precise surgical removal of soft tissues, and Solero microwave and radiofrequency systems, effective in ablating solid cancerous or benign growths. Additionally, they provide BioSentry tract sealant systems, IsoLoc Endorectal Balloons, Alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. Their endovascular therapies segment encompasses solutions for thrombus management, atherectomy procedures, core peripheral products, and the treatment of venous insufficiency. Furthermore, AngioDynamics is a key supplier of vascular access devices, such as peripherally inserted central catheters (PICCs), midline catheters, implantable ports, and dialysis catheters, along with associated accessories. These are primarily employed for short-duration systemic drug delivery, including chemotherapy and antibiotics, marketed under a robust portfolio of brand names such as BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax. The company distributes its offerings directly to a specialized clientele, including interventional radiologists, cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses, while also leveraging established distributor networks. Founded in 1988, AngioDynamics maintains its corporate headquarters in Latham, New York.
نطاق اليوم
السعر الحالي 11.23 US$
نطاق 52 أسبوعًا
السعر الحالي 11.23 US$
الربحية كنسبة مئوية من الإيرادات المعلنة.
الإيرادات
الدخل التشغيلي
صافي الدخل
| البند (USD) | السنة المالية 2026 | السنة المالية 2025 | السنة المالية 2024 | السنة المالية 2023 | السنة المالية 2022 |
|---|---|---|---|---|---|
| الإيرادات | 320.17 مليون USD | 292.5 مليون USD | 303.91 مليون USD | 338.75 مليون USD | 316.22 مليون USD |
| تكلفة البضاعة المباعة | 145.28 مليون USD | 134.79 مليون USD | 149.22 مليون USD | 164.51 مليون USD | 150.49 مليون USD |
| الربح الإجمالي | 174.89 مليون USD | 157.71 مليون USD | 154.7 مليون USD | 174.25 مليون USD | 165.73 مليون USD |
| البحث والتطوير | 29.45 مليون USD | 26.22 مليون USD | 31.51 مليون USD | 29.88 مليون USD | 30.74 مليون USD |
| مصاريف البيع والمصاريف العمومية والإدارية | 157.09 مليون USD | 145.23 مليون USD | 143.98 مليون USD | 144.25 مليون USD | 133.75 مليون USD |
| نفقات التشغيل | 214.82 مليون USD | 197.66 مليون USD | 347.13 مليون USD | 225.43 مليون USD | 194.2 مليون USD |
| دخل الفوائد | — | 978 ألف USD | 1.61 مليون USD | — | — |
| مصاريف الفوائد | 299 ألف USD | — | — | 2.7 مليون USD | 688 ألف USD |
| الاستهلاك والإطفاء | 22.96 مليون USD | 25.8 مليون USD | 27.71 مليون USD | 30.87 مليون USD | 29.35 مليون USD |
| الدخل التشغيلي | −39.93 مليون USD | −39.95 مليون USD | −192.44 مليون USD | −51.18 مليون USD | −28.47 مليون USD |
| صافي الدخل | −36.74 مليون USD | −33.99 مليون USD | −184.35 مليون USD | −52.44 مليون USD | −26.55 مليون USD |
تم تحديث حقائق الشركة 9 أكتوبر 2026.
أحدث النتائج المعلنة
أحدث النتائج المعلنة
قد تتغير تقديرات المحللين الخارجيين، وهي ليست توصيات من GoAI.
متوسط الهدف
19.50 US$
ارتفاع محتمل بنسبة 73.64%صناديق متداولة تفصح عن تعرضها لهذا السهم.
Vanguard Morningstar Total Stock Market ETFVTI18.92 مليون0.00%2.3 ترليون USD0.03%379.56 US$-0.39%
iShares Russell 2000 ETFIWM13.83 مليون0.02%77.7 مليار USD0.19%277.57 US$-0.05%
Vanguard Extended Market ETFVXF7.82 مليون0.01%95.4 مليار USD0.05%233.13 US$-0.15%
Dimensional - US Small Cap ETFDFAS4.56 مليون0.01%33.8 مليار USD0.31%78.10 US$+0.23%
Vanguard Russell 2000 ETFVTWO3.45 مليون0.02%18 مليار USD0.06%112.1 US$-0.10%
Schwab U.S. Small-Cap ETFSCHA2.79 مليون0.01%21.73 مليار USD0.03%32.66 US$+0.15%
Dimensional - US Core Equity 2 ETFDFAC2.78 مليون0.00%88.2 مليار USD0.21%45.11 US$-0.15%
iShares U.S. Medical Devices ETFIHI2.65 مليون0.08%3.53 مليار USD0.37%51.10 US$+0.29%
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Extended Market ETFVXF
Dimensional - US Small Cap ETFDFAS
Vanguard Russell 2000 ETFVTWO
Schwab U.S. Small-Cap ETFSCHA
Dimensional - US Core Equity 2 ETFDFAC
iShares U.S. Medical Devices ETFIHIالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.